Pharmaceutical Technology
JUNE 10, 2025
MSD research laboratories president Dean Li stated: “Enflonsia provides an important new preventive option to help protect healthy and at-risk infants born during or entering their first RSV season with the same dose regardless of weight. Give your business an edge with our leading industry insights.
Pharmaceutical Technology
JULY 14, 2025
MSD Research Laboratories global clinical development senior vice-president and head, chief medical officer Dr Eliav Barr stated: “MSD has been at the forefront of HIV research for more than 35 years and we are pleased to continue our work to innovate and deliver new options that aim to meet the needs of the HIV community.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 16, 2025
GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights.
Pharmaceutical Technology
AUGUST 17, 2022
These molecules synthesised newly are packaged densely into custom lipid nanoparticles (LNPs), which Orna has made to act on the body’s crucial tissues. By self-circularisation, Orna’s oRNA technology makes circular ribonucleic acids (oRNAs) from linear RNAs.
European Pharmaceutical Review
AUGUST 18, 2022
Newly synthesised oRNA molecules are more compactly packaged into custom LNPs, which Orna has engineered to target key tissues in the body. Orna’s proprietary oRNA technology creates circular RNAs from linear RNAs by self-circularisation. We look forward to working with the talented scientific and technical teams at Orna.”
Expert insights. Personalized for you.
Let's personalize your content